[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (1,441)

Search Parameters:
Keywords = bone mineral density

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
16 pages, 2317 KiB  
Article
Associations of Perchlorate, Nitrate, and Thiocyanate with Bone Mineral Density in the US General Population: A Multi-Cycle Study of NHANES 2011–2018
by Donglan Wang, Ying Zhang, Yayu He, Fengmei Song, Yan Tang, Limou Chen, Yangcan Wang, Fei Yang and Xueqiong Yao
Nutrients 2024, 16(16), 2658; https://doi.org/10.3390/nu16162658 (registering DOI) - 11 Aug 2024
Abstract
Background: Perchlorate, nitrate, and thiocyanate are widely recognized as endocrine disrupting chemicals, which are closely related to thyroid function. Animal and human studies show a correlation between thyroid hormone and bone mineral density (BMD). However, it remains unknown whether perchlorate, nitrate, and thiocyanate [...] Read more.
Background: Perchlorate, nitrate, and thiocyanate are widely recognized as endocrine disrupting chemicals, which are closely related to thyroid function. Animal and human studies show a correlation between thyroid hormone and bone mineral density (BMD). However, it remains unknown whether perchlorate, nitrate, and thiocyanate were associated with BMD. This study aimed to explore the association between perchlorate, nitrate, and thiocyanate exposure with BMD. Method: A cross-sectional analysis among 5607 participants from the 2011–2018 National Health and Nutrition Examination Survey (NHANES) was conducted in the present study. Perchlorate, nitrate, and thiocyanate were detected in urine by ion chromatography. Survey-weighted generalized linear regression, restricted cubic splines, and qgcomp models were used to assess the association of BMDs with single and mixed perchlorate, nitrate, and thiocyanate exposures. In addition, age, gender, and BMI stratified these associations. Results: Negative associations were found between perchlorate and nitrate with BMDs. Furthermore, based on the qgcomp model results, the combined association of perchlorate, nitrate, and thiocyanate exposure was negatively associated with BMDs (β = −0.017, 95% CI: −0.041, −0.024 for total BMD; β = −0.017, 95% CI: −0.029, −0.005 for lumbar BMD). Additionally, there was a significant effect after gender, age, and BMI stratification between perchlorate, nitrate, and thiocyanate with BMDs in the normal weight group (β = −0.015, 95% CI: −0.020, −0.011 for total BMD; β = −0.022, 95% CI: −0.028, −0.016 for lumbar BMD) and children and adolescents group (β = −0.025, 95% CI: −0.031, −0.019 for total BMD; β −0.017, 95% CI: −0.029, −0.005 for lumbar BMD). Conclusions: The present study indicated a negative correlation between BMDs and urinary perchlorate, nitrate, and thiocyanate levels, with nitrate being the main contributor to the mixture effect. People with normal weight and children and adolescents were more likely to be affected. Full article
(This article belongs to the Section Nutritional Epidemiology)
Show Figures

Figure 1

Figure 1
<p>Flow diagram of participant selection in NHANES 2011–2018. Abbreviations: NHANES, National Health and Nutrition Examination Survey; BMD, bone mineral density.</p>
Full article ">Figure 2
<p>Spearman rank correlation matrix for urinary perchlorate, nitrate, and thiocyanate measured in the population (<span class="html-italic">n</span> = 5607), NHANES 2011–2018.</p>
Full article ">Figure 3
<p>Predicted cubic splines for the associations of urinary perchlorate, nitrate, and thiocyanate with BMDs. The relationship between total BMD and urinary perchlorate (<b>A</b>), nitrate (<b>B</b>), and thiocyanate (<b>C</b>). The relationship between lumbar BMD and urinary perchlorate (<b>D</b>), nitrate (<b>E</b>), and thiocyanate (<b>F</b>). Models were adjusted for age, gender, body mass index, race, income to poverty ratio, education, serum cotinine levels, drinking, exercise, serum 25 (OH) D, thyroid problems, hypertension, diabetes, urinary perchlorate, nitrate, and thiocyanate levels. Abbreviations: BMD, bone mineral density; CI, confidence interval; <span class="html-italic">p</span> for trend of urinary perchlorate, nitrate, and thiocyanate.</p>
Full article ">Figure 4
<p>Association of co-exposure of perchlorate, nitrate, and thiocyanate with total BMD (<b>A</b>) and lumbar BMD (<b>B</b>) by qgcomp models. Models were adjusted for age, gender, body mass index, race, income to poverty ratio, education, serum cotinine levels, drinking, exercise, serum 25 (OH) D, thyroid problems, hypertension, diabetes, urinary perchlorate, nitrate, and thiocyanate levels. Abbreviations: BMD, bone mineral density; CI, confidence interval.</p>
Full article ">Figure 5
<p>Regression coefficients and 95% confidence intervals (95% CIs) between BMDs with urinary perchlorate, nitrate, and thiocyanate concentrations in NHANES 2011–2018, stratified by subgroups. Models were adjusted for age, gender, body mass index, race, income-to-poverty ratio, education, serum cotinine levels, drinking, exercise, serum 25 (OH) D, thyroid problems, hypertension, and diabetes, except for the stratified variable. Abbreviations: BMD, bone mineral density; CI, confidence interval.</p>
Full article ">
20 pages, 3114 KiB  
Review
The Manganese–Bone Connection: Investigating the Role of Manganese in Bone Health
by Gulaim Taskozhina, Gulnara Batyrova, Gulmira Umarova, Zhamilya Issanguzhina and Nurgul Kereyeva
J. Clin. Med. 2024, 13(16), 4679; https://doi.org/10.3390/jcm13164679 - 9 Aug 2024
Viewed by 403
Abstract
The complex relationship between trace elements and skeletal health has received increasing attention in the scientific community. Among these minerals, manganese (Mn) has emerged as a key element affecting bone metabolism and integrity. This review examines the multifaceted role of Mn in bone [...] Read more.
The complex relationship between trace elements and skeletal health has received increasing attention in the scientific community. Among these minerals, manganese (Mn) has emerged as a key element affecting bone metabolism and integrity. This review examines the multifaceted role of Mn in bone health, including its effects on bone regeneration, mineralization, and overall skeletal strength. This review article is based on a synthesis of experimental models, epidemiologic studies, and clinical trials of the mechanisms of the effect of Mn on bone metabolism. Current research data show that Mn is actively involved in the processes of bone remodeling by modulating the activity of osteoblasts and osteoclasts, as well as the main cells that regulate bone formation and resorption. Mn ions have a profound effect on bone mineralization and density by intricately regulating signaling pathways and enzymatic reactions in these cells. Additionally, Mn superoxide dismutase (MnSOD), located in bone mitochondria, plays a crucial role in osteoclast differentiation and function, protecting osteoclasts from oxidative damage. Understanding the nuances of Mn’s interaction with bone is essential for optimizing bone strategies, potentially preventing and managing skeletal diseases. Key findings include the stimulation of osteoblast proliferation and differentiation, the inhibition of osteoclastogenesis, and the preservation of bone mass through the RANK/RANKL/OPG pathway. These results underscore the importance of Mn in maintaining bone health and highlight the need for further research into its therapeutic potential. Full article
Show Figures

Figure 1

Figure 1
<p>The role of manganese (Mn) in bone cellular and molecular functions. The trace element Mn, with its various biochemical and physiological effects, participates in the synthesis of bone matrix, the inhibition of the formation of osteoclast-like cells, antioxidant function with the enzyme Mn superoxide dismutase (MnSOD), and mRNA expression of RANKL receptors; it also contributes to cell adhesion with extracellular matrix proteins, regulating osteoid formation. It also protects cartilage and stimulates chondrocyte growth through ZIP14. This is important for its integrin-activating functions, which contribute to the adhesion, integrity, and proliferation of osteoblasts.</p>
Full article ">Figure 2
<p>Manganese (Mn) superoxide dismutase (MnSOD) in the bone resorption [<a href="#B52-jcm-13-04679" class="html-bibr">52</a>]. RANKL-induced differentiation of macrophages into osteoclasts and the role of MnSOD in managing oxidative stress during bone resorption are depicted. RANKL binds to the RANK receptors on these cells, promoting their maturation. During bone resorption, superoxide (O<sub>2</sub><sup>−</sup>) is produced as a byproduct, and the mitochondrial enzyme MnSOD catalyzes the conversion of O<sub>2</sub><sup>−</sup> into hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and oxygen (O<sub>2</sub>), thereby reducing oxidative stress. H<sub>2</sub>O<sub>2</sub> is subsequently converted into water (H<sub>2</sub>O), providing cellular protection. This process underscores the critical role of MnSOD in maintaining the functionality and integrity of osteoclasts during bone resorption.</p>
Full article ">Figure 3
<p>Manganese (Mn) and bone remodeling [<a href="#B72-jcm-13-04679" class="html-bibr">72</a>]. The role of Mn in bone remodeling highlights its dual impact on osteoclasts and osteoblasts. Mn promotes osteoclast differentiation by enhancing the RANKL/RANK signaling pathway, where RANKL binds to RANK receptors on osteoclast progenitor cells, leading to their maturation into osteoclasts. Mature osteoclasts resorb bone, a process associated with oxidative stress, during which O<sub>2</sub><sup>−</sup> is converted into less harmful molecules by the mitochondrial enzyme Mn superoxide dismutase (MnSOD). Concurrently, Mn inhibits the PI3K/AKT and WNT/β-catenin signaling pathways in mesenchymal stem cells (MSCs), thereby reducing the differentiation and activity of osteoblasts. This dual mechanism underscores the essential role of Mn in maintaining bone mass and integrity, ensuring effective bone regeneration and homeostasis by balancing bone resorption and formation.</p>
Full article ">Figure 4
<p>Molecular mechanisms of manganese (Mn) metabolism. The molecular pathways involved in Mn metabolism highlight its absorption, transport, and accumulation in the body. Mn ions (Mn<sup>2+</sup>) are absorbed in the intestines through the divalent metal transporter 1 (DMT1). After absorption, Mn<sup>2+</sup> ions enter the bloodstream and are transported in a complex with proteins. The liver, considered the central organ in Mn metabolism, plays a crucial role in processing and regulating Mn levels. Mn is then distributed from the liver to various tissues throughout the body, with a significant accumulation in the bones. This high accumulation in bones underscores the essential role of Mn in skeletal health.</p>
Full article ">Figure 5
<p>Manganese (Mn) hemostasis in the bone [<a href="#B90-jcm-13-04679" class="html-bibr">90</a>]. The cellular mechanisms involved in maintaining Mn homeostasis in bones reveal the key physiological functions of Mn transporters and regulators, including ZIP8, ZNT10, and ZIP14. The process begins with the intake of Mn from food, where ZIP8 facilitates the intracellular accumulation of Mn<sup>2+</sup> ions. These Mn<sup>2+</sup> ions enter the bloodstream and are transported to various tissues, including bones and liver hepatocytes. The transport of Mn<sup>2+</sup> ions into bones and other tissues is facilitated by the ubiquitously expressed ZIP14. Mn<sup>2+</sup> ions reach the liver, where they undergo further processing and regulation. The ZIP10 transporter acts as an apical exporter, transporting Mn from the blood to the lumen of the small intestine for excretion in feces. These intricate regulatory mechanisms ensure the balance of Mn, which is crucial for maintaining bone health and overall metabolic homeostasis.</p>
Full article ">
11 pages, 573 KiB  
Article
The Utility of Radiomorphometric Mandibular Indices on Cone Beam Computer Tomography in the Assessment of Bone Mass in Postmenopausal Women: A Cross-Sectional Study
by Ioana Ruxandra Poiană, Ramona Dobre, Silviu-Mirel Pițuru and Alexandru Bucur
J. Pers. Med. 2024, 14(8), 843; https://doi.org/10.3390/jpm14080843 - 9 Aug 2024
Viewed by 162
Abstract
Background: The present study examined the potential use of computed tomography radiomorphometric mandibular indices on cone beam CT (CBCT) for the assessment of bone density in postmenopausal women with low bone mass. Methods: We included 104 postmenopausal women who received dual-energy X-ray absorptiometry [...] Read more.
Background: The present study examined the potential use of computed tomography radiomorphometric mandibular indices on cone beam CT (CBCT) for the assessment of bone density in postmenopausal women with low bone mass. Methods: We included 104 postmenopausal women who received dual-energy X-ray absorptiometry (DXA) using a DXA scanner and mental foramen (MF) region CBCT using a NewTom VGi EVO Cone Beam 3D system. We assessed the relationships between the following DXA parameters: lumbar, femoral neck, and total hip T-scores, bone mineral density (BMD), lumbar trabecular bone score (TBS), and mandibular inferior cortical bone thickness at 4 sites. The cross-sectional images were obtained, as follows: anterior (A)—10 mm anterior from the MF; molar (M)—10 mm posterior from the MF; posterior (P)—25 mm posterior from the MF; symphysis (S)—equidistant from the centers of the right and left MF. Results: We found that A and M indices showed statistically significant moderate positive correlations with lumbar spine, femoral neck, and total hip BMD, as well as TBS. The P index demonstrated moderate positive correlations with these measurements, while the S index did not show significant correlations with BMD or TBS in postmenopausal women. Conclusions: These findings support the potential usefulness of CBCT-derived radiomorphometric mandibular indices for non-invasive bone health assessment in clinical practice. Full article
(This article belongs to the Topic Advances in Dental Health)
Show Figures

Figure 1

Figure 1
<p>Index measurements in cross-sectional images: (<b>A</b>) (S index, symphysis)—the thickness of the mandibular inferior cortex equidistant from the centers of the right and left mental foramina; (<b>B</b>) (A index, anterior)—the thickness of the mandibular inferior cortex 10 mm anterior to the mental foramina; (<b>C</b>) (M index, molar)—the thickness of the mandibular inferior cortex 10 mm posterior to the mental foramina; (<b>D</b>) (P index, posterior)—the thickness of the mandibular inferior cortex 25 mm posterior to the mental foramina.</p>
Full article ">
17 pages, 881 KiB  
Review
Is Raman Spectroscopy of Fingernails a Promising Tool for Diagnosing Systemic and Dermatological Diseases in Adult and Pediatric Populations?
by Teresa Tabasz, Natalia Szymańska, Katarzyna Bąk-Drabik, Aleksandra Damasiewicz-Bodzek and Agnieszka Nowak
Medicina 2024, 60(8), 1283; https://doi.org/10.3390/medicina60081283 - 9 Aug 2024
Viewed by 248
Abstract
Background: Raman spectroscopy is a well-known tool used in criminology, molecular biology, and histology. It is also applied to diagnose bone mineral disorders by taking advantage of the similarity of the structure of keratin and bone collagen. Raman spectroscopy can also be [...] Read more.
Background: Raman spectroscopy is a well-known tool used in criminology, molecular biology, and histology. It is also applied to diagnose bone mineral disorders by taking advantage of the similarity of the structure of keratin and bone collagen. Raman spectroscopy can also be used in dermatology and diabetology. The purpose of the present review is to critically evaluate the available research about the use of Raman spectroscopy in the mentioned areas of medicine. Methodology: PubMed was searched for peer-reviewed articles on the subject of use of Raman spectroscopy in bone mineral disorders, dermatology, and diabetes mellitus. Results: Nail keratin and bone collagen are related structural proteins that require disulfide bond for structural stability. Therefore, Raman spectroscopy of keratin may have potential as a diagnostic tool for screening bone quality and distinguishing patients at risk of fracture for reasons different from low bone mineral density (BMD) in the adult women population. Raman spectroscopy can also investigate the changes in keratin’s structure in nails affected by onychomycosis and distinguish between healthy and onychomycosis nail samples. It could also reduce the need for nail biopsy by distinguishing between dermatophytic and non-dermatophytic agents of onychomycosis. Additionally, Raman spectroscopy could expedite the diagnostic process in psoriasis (by assessing the secondary structure of keratin) and in diabetes mellitus (by examining the protein glycation level). Conclusions: In adult populations, Raman spectroscopy is a promising and safe method for assessing the structure of fingernails. However, data are scarce in the pediatric population; therefore, more studies are required in children. Full article
Show Figures

Figure 1

Figure 1
<p>The principle of operation of Raman spectroscopy.</p>
Full article ">Figure 2
<p>The concept behind the use of Raman spectroscopy in the diagnosis of bone structure disorders.</p>
Full article ">
23 pages, 1736 KiB  
Review
Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis
by Yi Chen, Hefang Xiao, Zirui Liu, Fei Teng, Ao Yang, Bin Geng, Xiaoyun Sheng and Yayi Xia
Biomolecules 2024, 14(8), 970; https://doi.org/10.3390/biom14080970 - 8 Aug 2024
Viewed by 271
Abstract
Osteoporosis (OP) is a common metabolic bone disease characterized by low bone mass, decreased bone mineral density, and degradation of bone tissue microarchitecture. However, our understanding of the mechanisms of bone remodeling and factors affecting bone mass remains incomplete. Sirtuin1 (SIRT1) is a [...] Read more.
Osteoporosis (OP) is a common metabolic bone disease characterized by low bone mass, decreased bone mineral density, and degradation of bone tissue microarchitecture. However, our understanding of the mechanisms of bone remodeling and factors affecting bone mass remains incomplete. Sirtuin1 (SIRT1) is a nicotinamide adenine dinucleotide-dependent deacetylase that regulates a variety of cellular metabolisms, including inflammation, tumorigenesis, and bone metabolism. Recent studies have emphasized the important role of SIRT1 in bone homeostasis. This article reviews the role of SIRT1 in bone metabolism and OP and also discusses therapeutic strategies and future research directions for targeting SIRT1. Full article
Show Figures

Figure 1

Figure 1
<p>Bone remodeling cycle under physiological and pathological conditions. (1) The resorption phase, in which osteoclast precursors are induced by RANKL and M-CSF to differentiate into mature multinucleated osteoclasts. In this stage, mature osteoclasts with characteristic folded edges resorb bone by secreting Cathepsin K, H<sup>+</sup>, and Cl<sup>−</sup> in the confined zone, and then detach from the bone surface and apoptose [<a href="#B6-biomolecules-14-00970" class="html-bibr">6</a>]. (2) The reversal stage, in which osteoblasts are differentiated and recruited to the resorption site in response to Wnt, BMP, and TGF-β. (3) The formative stage, in which osteoclasts form a new organic bone matrix. (4) Eventually, mineralization occurs. In conditions such as lack of estrogen or inflammation, other immune cells provide RANKL, leading to enhanced osteoclast activity and increased bone resorption [<a href="#B44-biomolecules-14-00970" class="html-bibr">44</a>]. HSC, hematopoietic stem cell; M-CSF, macrophage colony-stimulating factor; RANK, receptor activator of nuclear factor-κB; RANKL, receptor activator of nuclear factor-κB ligand; OPG, osteoprotegerin; MSC, mesenchymal stromal cell; BMPs, bone morphogenetic proteins; TGF-β, transforming growth factor-β. Created by Figdraw.com (<a href="https://www.figdraw.com" target="_blank">https://www.figdraw.com</a>).</p>
Full article ">Figure 2
<p>Model of the upstream pathways targeting SIRT1 in control of bone homeostasis. SIRT1 is a NAD+-dependent enzyme, NMN is a precursor substance for NAD+, and NAMPT is a reliable biomarker of osteogenic differentiation [<a href="#B141-biomolecules-14-00970" class="html-bibr">141</a>]. The AMPK pathway can activate SIRT1 through the AMPK/NAMPT pathway, increasing the NAD+/NADH ratio, which is mainly involved in energy metabolism [<a href="#B142-biomolecules-14-00970" class="html-bibr">142</a>,<a href="#B143-biomolecules-14-00970" class="html-bibr">143</a>,<a href="#B144-biomolecules-14-00970" class="html-bibr">144</a>,<a href="#B145-biomolecules-14-00970" class="html-bibr">145</a>,<a href="#B146-biomolecules-14-00970" class="html-bibr">146</a>]. MiRNAs can bind to the mRNA of SIRT1, thereby inhibiting its translation process [<a href="#B147-biomolecules-14-00970" class="html-bibr">147</a>]. Excess ROS can oxidize cysteine residues that modify SIRT1, thereby inhibiting SIRT1 [<a href="#B149-biomolecules-14-00970" class="html-bibr">149</a>]. Estrogen can up-regulate SIRT1 expression [<a href="#B30-biomolecules-14-00970" class="html-bibr">30</a>]. NMN, nicotinamide mononucleotide; NAMPT, nicotinamide phosphoribosyltransferase; NAD+, nicotinamide adenine dinucleotide; NADH, nicotinamide adenine dinucleotide hydride; miRNAs, microRNAs. Created by Figdraw.com (<a href="https://www.figdraw.com" target="_blank">https://www.figdraw.com</a>).</p>
Full article ">Figure 3
<p>SIRT1 maintains bone homeostasis by targeting a series of downstream signaling pathways. SIRT1 regulates bone formation and bone resorption through osteoblasts, osteoclasts, and BMSCs. Wnt/β-catenin, wingless-related integration site/Beta-catenin; FoxOs, forkhead box O; PGC-1α, peroxisome proliferator-activated receptor-gamma coactivator 1-alpha; ECM, extracellular matrix; NF-κB, nuclear factor kappa B; BMSCs, bone marrow-derived mesenchymal stromal cells. Created by Figdraw.com (<a href="https://www.figdraw.com" target="_blank">https://www.figdraw.com</a>).</p>
Full article ">
13 pages, 584 KiB  
Article
Pro-Osteogenic Effect of the Nutraceutical BlastiMin Complex® in Women with Osteoporosis or Osteopenia: An Open Intervention Clinical Trial
by Sofia Sabatelli, Emanuele-Salvatore Scarpa, Angelica Giuliani, Chiara Giordani, Jacopo Sabbatinelli, Maria Rita Rippo, Sara Cabodi, Barbara Petrini, Giancarlo Balercia and Gilberta Giacchetti
Int. J. Mol. Sci. 2024, 25(16), 8565; https://doi.org/10.3390/ijms25168565 - 6 Aug 2024
Viewed by 260
Abstract
Osteoporosis is a chronic disease that affects millions of patients worldwide and is characterized by low bone mineral density (BMD) and increased risk of fractures. Notably, natural molecules can increase BMD and exert pro-osteogenic effects. Noteworthily, the nutraceutical BlastiMin Complex® (Mivell, Italy, [...] Read more.
Osteoporosis is a chronic disease that affects millions of patients worldwide and is characterized by low bone mineral density (BMD) and increased risk of fractures. Notably, natural molecules can increase BMD and exert pro-osteogenic effects. Noteworthily, the nutraceutical BlastiMin Complex® (Mivell, Italy, European Patent Application EP4205733A1) can induce differentiation of human bone marrow mesenchymal stem cells (BM-MSCs) in osteoblasts and can exert in vitro pro-osteogenic and anti-inflammatory effects. Thus, the purpose of this study was to verify the effects of BlastiMin Complex® on bone turnover markers (BTMs) and BMD in patients with senile and postmenopausal osteopenia or osteoporosis. The efficacy of BlastiMin Complex® on BTMs in serum was evaluated through biochemical assays. BMD values were analyzed by dual-energy X-ray absorptiometry (DXA) and Radiofrequency Echographic Multi Spectrometry (R.E.M.S.) techniques, and the SNPs with a role in osteoporosis development were evaluated by PCR. Clinical data obtained after 12 months of treatment showed an increase in bone turnover index, a decrease in C-reactive protein levels, and a remarkable increase in P1NP levels, indicating the induction of osteoblast proliferation and activity in the cohort of 100% female patients recruited for the study. These findings show that the nutraceutical BlastiMin Complex® could be used as an adjuvant in combination with synthetic drugs for the treatment of osteoporosis pathology. Full article
(This article belongs to the Topic Bone as an Endocrine Organ)
Show Figures

Figure 1

Figure 1
<p>Flowchart diagram of the BlastiMin Complex<sup>®</sup> clinical trial.</p>
Full article ">
19 pages, 4612 KiB  
Article
Tibial Damage Caused by T-2 Toxin in Goslings: Bone Dysplasia, Poor Bone Quality, Hindered Chondrocyte Differentiation, and Imbalanced Bone Metabolism
by Wang Gu, Lie Hou, Qiang Bao, Qi Xu and Guohong Chen
Animals 2024, 14(15), 2281; https://doi.org/10.3390/ani14152281 - 5 Aug 2024
Viewed by 303
Abstract
T-2 toxin, the most toxic type A trichothecene, is widely present in grain and animal feed, causing growth retardation and tissue damage in poultry. Geese are more sensitive to T-2 toxin than chickens and ducks. Although T-2 toxin has been reported to cause [...] Read more.
T-2 toxin, the most toxic type A trichothecene, is widely present in grain and animal feed, causing growth retardation and tissue damage in poultry. Geese are more sensitive to T-2 toxin than chickens and ducks. Although T-2 toxin has been reported to cause tibial growth plate (TGP) chondrodysplasia in chickens, tibial damage caused by T-2 toxin in geese has not been fully demonstrated. This study aims to investigate the adverse effects of T-2 toxin on tibial bone development, bone quality, chondrocyte differentiation, and bone metabolism. Here, forty-eight one-day-old male Yangzhou goslings were randomly divided into four groups and daily gavaged with T-2 toxin at concentrations of 0, 0.5, 1.0, and 2.0 mg/kg body weight for 21 days, respectively. The development of gosling body weight and size was determined by weighing and taking body measurements after exposure to different concentrations of T-2 toxin. Changes in tibial development and bone characteristics were determined by radiographic examination, phenotypic measurements, and bone quality and composition analyses. Chondrocyte differentiation in TGP and bone metabolism was characterized by cell morphology, tissue gene-specific expression, and serum marker levels. Results showed that T-2 toxin treatment resulted in a lower weight, volume, length, middle width, and middle circumference of the tibia in a dose-dependent manner (p < 0.05). Moreover, decreased bone-breaking strength, bone mineral density, and contents of ash, Ca, and P in the tibia were observed in T-2 toxin-challenged goslings (p < 0.05). In addition, T-2 toxin not only reduced TGP height (p < 0.05) but also induced TGP chondrocytes to be disorganized with reduced numbers and indistinct borders. As expected, the apoptosis-related genes (CASP9 and CASP3) were significantly up-regulated in chondrocytes challenged by T-2 toxin with a dose dependence, while cell differentiation and maturation-related genes (BMP6, BMP7, SOX9, and RUNX2) were down-regulated (p < 0.05). Considering bone metabolism, T-2 toxin dose-dependently and significantly induced a decreased number of osteoblasts and an increased number of osteoclasts in the tibia, with inhibited patterns of osteogenesis-related genes and enzymes and increased patterns of osteoclast-related genes and enzymes (p < 0.05). Similarly, the serum Ca and P concentrations and parathyroid hormone, calcitonin, and 1, 25-dihydroxycholecalciferol levels decreased under T-2 toxin exposure (p < 0.05). In summary, 2.0 mg/kg T-2 toxin significantly inhibited tibia weight, length, width, and circumference, as well as decreased bone-breaking strength, density, and composition (ash, calcium, and phosphorus) in 21-day-old goslings compared to the control and lower dose groups. Chondrocyte differentiation in TGP was delayed by 2.0 mg/kg T-2 toxin owing to cell apoptosis. In addition, 2.0 mg/kg T-2 toxin promoted bone resorption and inhibited osteogenesis in cellular morphology, gene expression, and hormonal modulation patterns. Thus, T-2 toxin significantly inhibited tibial growth and development with a dose dependence, accompanied by decreased bone geometry parameters and properties, hindered chondrocyte differentiation, and imbalanced bone metabolism. Full article
Show Figures

Figure 1

Figure 1
<p>The schematic diagram and experimental strategy of tibial damage caused by T-2 toxin in goslings. T-2, T-2 toxin; TGP, tibial growth plate; HE, hematoxylin–eosin; AB, alcian blue; SF, safranin O-fast green; TRAP, tartrate-resistant acid phosphatase; RT-qPCR, real-time quantitative PCR; OB, osteoblast; OC, osteoclast.</p>
Full article ">Figure 2
<p>Phenotypic and radiographic observations of the tibia in goslings under T-2 toxin exposure through morphological image capture (<b>A</b>), X-ray examination (<b>B</b>), and CT scan (<b>C</b>). Ⅰ, 0 mg/kg T-2 toxin group; Ⅱ, 0.5 mg/kg T-2 toxin group; Ⅲ, 1.0 mg/kg T-2 toxin group; and Ⅳ, 2.0 mg/kg T-2 toxin group. The red arrow refers to the tibial growth plate. CT values in the selected area were detected, indicating bone mineral density in the bone plane.</p>
Full article ">Figure 3
<p>Morphological and structural changes in chondrocytes in the tibial growth plate (TGP) under T-2 toxin exposure. Ⅰ, 0 mg/kg T-2 toxin group; Ⅱ, 0.5 mg/kg T-2 toxin group; Ⅲ, 1.0 mg/kg T-2 toxin group; and Ⅳ, 2.0 mg/kg T-2 toxin group; (<b>A</b>) The phenotype of the tibial growth plate with a scale bar of 10 mm. Differences in TGP height were analyzed by one-way ANOVA analysis. <span class="html-italic">n</span> = 12, 9, 10, and 7, respectively. <sup>a–c</sup> Means within a row with no common superscript differ significantly (<span class="html-italic">p</span> &lt; 0.05). (<b>B</b>) Chondrocyte damage in the reserve zone (RZ), proliferative zone (PZ), hypertrophic zone (HZ), and calcified zone (CZ) of TGP through hematoxylin–eosin (HE), alcian blue (AB), and safranin O-fast green (SF) staining with a scale bar of 1000 μm. The representative images of higher magnifications of TGP with a scale bar of 20 μm in HE staining are shown in <a href="#app1-animals-14-02281" class="html-app">Supplementary Figure S1</a>. (<b>C</b>) Expression patterns of chondrocyte development-related genes in TGP chondrocytes. <span class="html-italic">BMP</span>, bone morphogenetic protein; <span class="html-italic">SOX9</span>, SRY-box transcription factor 9; <span class="html-italic">RUNX2</span>, RUNX family transcription factor 2. Differences in gene expressions were analyzed by one-way ANOVA analysis. <span class="html-italic">n</span> = 6. <sup>a–d</sup> Means within a row with no common superscript differ significantly (<span class="html-italic">p</span> &lt; 0.05). (<b>D</b>) Expression patterns of apoptosis-related genes in TGP chondrocytes. <span class="html-italic">BAK1</span>, BCL2 antagonist/killer 1; <span class="html-italic">BCL2</span>, BCL2 apoptosis regulator; <span class="html-italic">CASP</span>, caspase. Differences in gene expressions were analyzed by one-way ANOVA analysis. <span class="html-italic">n</span> = 6. <sup>a–c</sup> Means within a row with no common superscript differ significantly (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 4
<p>Effects of T-2 toxin on bone metabolism: bone formation (osteogenesis) and resorption (osteoclastogenesis) in the calcified zone of the tibia. (<b>A</b>) Changes in the number of osteoblasts and osteoclasts with a scale bar of 100 μm. Ⅰ, 0 mg/kg T-2 toxin group; Ⅱ, 0.5 mg/kg T-2 toxin group; Ⅲ, 1.0 mg/kg T-2 toxin group; and Ⅳ, 2.0 mg/kg T-2 toxin group; HE, hematoxylin–eosin; TRAP, tartrate-resistant acid phosphatase; OB, osteoblast (green arrow); OC, osteoclast (red arrow); C, chondrocyte; TB, trabecular bone; BM, bone marrow. Osteoblasts are polygonal or cuboidal in shape, arranged in a single layer on the surface of the newly formed bone matrix. Osteoclasts are large multinucleated cells (<span class="html-italic">n</span> ≥ 3) that usually show intense red or purple coloring in TRAP staining. Osteoblasts and osteoclasts were counted in five randomly selected fields of HE and TRAP staining, respectively, with a scale bar of 100 μm, and the mean values were used as a representative value for the individual sample within the group for subsequent significance analysis. Differences in cell numbers were analyzed by one-way ANOVA analysis. <span class="html-italic">n</span> = 12, 9, 10, and 7, respectively. <sup>a–c</sup> Means within a row with no common superscript differ significantly (<span class="html-italic">p</span> &lt; 0.05). The representative images of higher magnifications of osteoblasts and osteoclasts with a scale bar of 20 μm are shown in <a href="#app1-animals-14-02281" class="html-app">Supplementary Figure S2</a>. (<b>B</b>) Changes in the expression of genes associated with bone formation and bone resorption in the tibia. <span class="html-italic">BGP</span>, bone gamma-carboxyglutamate protein; <span class="html-italic">OPG</span>, osteoprotegerin; <span class="html-italic">RANKL</span>, receptor activator of nuclear factor kappa B ligand; <span class="html-italic">RANK</span>, receptor activator of nuclear factor kappa B. Differences in gene expressions were analyzed by one-way ANOVA analysis. <span class="html-italic">n</span> = 6. <sup>a–d</sup> Means within a row with no common superscript differ significantly (<span class="html-italic">p</span> &lt; 0.05). (<b>C</b>) Changes in the serum activity of enzymes associated with bone formation and bone resorption. ALP, alkaline phosphatase. Differences in enzyme activities were analyzed by one-way ANOVA analysis. <span class="html-italic">n</span> = 12, 9, 10, and 7, respectively. <sup>a–c</sup> Means within a row with no common superscript differ significantly (<span class="html-italic">p</span> &lt; 0.05). (<b>D</b>) Changes in the serum calcium (Ca) and phosphorus (P) concentrations and hormone levels associated with bone metabolism. PTH, parathyroid hormone; CT, calcitonin; 1,25-(OH)<sub>2</sub>-D<sub>3</sub>, 1,25-dihydroxyvitamin D<sub>3</sub>. Differences in Ca and P concentrations and enzyme activities were analyzed by one-way ANOVA analysis. <span class="html-italic">n</span> = 12, 9, 10, and 7, respectively. <sup>a–c</sup> Means within a row with no common superscript differ significantly (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">
15 pages, 669 KiB  
Article
Relationship between Body Mass Index and Health-Related Physical Fitness Components in HIV-Diagnosed Children and Adolescents
by João Antônio Chula de Castro, Luiz Rodrigo Augustemak de Lima and Diego Augusto Santos Silva
Children 2024, 11(8), 938; https://doi.org/10.3390/children11080938 - 2 Aug 2024
Viewed by 407
Abstract
Background/Objectives: There is a need to monitor physical fitness in HIV-diagnosed children and adolescents, and body mass index (BMI) could be an option for this due to its usability for assessing nutritional status and fat mass. The present study aimed to explore the [...] Read more.
Background/Objectives: There is a need to monitor physical fitness in HIV-diagnosed children and adolescents, and body mass index (BMI) could be an option for this due to its usability for assessing nutritional status and fat mass. The present study aimed to explore the relationship between BMI and physical fitness in HIV-diagnosed children and adolescents. Methods: A cross-sectional study was conducted with 86 HIV-diagnosed children and adolescents aged 5–15, with participants from two research protocols (Study I, n = 65; Study II, n = 21). Physical fitness was assessed through body composition (anthropometric measurements and dual energy X-ray absorptiometry), cardiorespiratory fitness (peak oxygen consumption [VO2peak]), muscle strength/endurance (handgrip strength, standing broad jump, and abdominal and modified push-up endurance), and flexibility (sit-to reach test). The relationship between BMI and physical fitness components was analyzed through correlation and simple and multiple linear regression analysis. Results: Eutrophic participants (mean age 11.44 ± 2.20) presented a normal fat mass percentage and overweight participants (mean age 11.50 ± 2.54) presented adequate handgrip strength. The adjusted models could explain 71% of fat-free mass, 57% of fat mass percentage, 70% of bone mineral content, 72% of bone mineral density, and 52% of handgrip strength. Conclusions: Increases in BMI were associated with increases in fat-free mass, fat mass percentage, bone mineral content, bone mineral density, and handgrip strength. BMI was capable of distinguishing those presenting a normal fat mass percentage and those presenting adequate handgrip strength. Full article
Show Figures

Figure 1

Figure 1
<p>Correlation between BMI and health-related physical fitness components, scatterplot analysis. BMI: body mass index; BMC: bone mineral content; BMD: bone mineral density. (<b>a</b>) fat-free mass; (<b>b</b>) fat mass percentage; (<b>c</b>) bone mineral content; (<b>d</b>) bone mineral density; (<b>e</b>) handgrip strength.</p>
Full article ">
11 pages, 4437 KiB  
Article
Effects of Aging on New Bone Regeneration in a Mandibular Bone Defect in a Rat Model
by Jung Ho Park, Jong Hoon Park, Hwa Young Yu and Hyun Seok
Biomimetics 2024, 9(8), 466; https://doi.org/10.3390/biomimetics9080466 - 1 Aug 2024
Viewed by 365
Abstract
The effects of aging on the healing capacity of maxillofacial bone defects have not been studied. The aim of this study was to evaluate the effects of aging on the regeneration of round bony defects in the mandible. We created a round-shaped bony [...] Read more.
The effects of aging on the healing capacity of maxillofacial bone defects have not been studied. The aim of this study was to evaluate the effects of aging on the regeneration of round bony defects in the mandible. We created a round-shaped bony defect in the mandibular angle area in rats of different ages (2-[2 M], 10-[10 M], and 20-month-old [20 M]) and evaluated new bone regeneration in these groups. Changes in bone turnover markers such as alkaline phosphatase, procollagen type I N-terminal propeptide (PINP), cross-linked C-telopeptide of type I collagen, and tartrate-resistant acid phosphatase 5B (TRAP5b) were investigated. The bone volume/total volume and bone mineral density of the 20 M group were significantly higher than those of the 2 M group (p = 0.029, 0.019). A low level of the bone formation marker PINP was observed in the 20 M group, and a high level of the bone resorption marker TRAP5b was observed in the 10 M and 20 M groups. Micro-computed tomography (µ-CT) results showed that older rats had significantly higher bone formation than younger rats, with lower serum levels of PINP and higher levels of TRAP5b. The local environment of the old rat bone defects, surrounded by thickened bone, may have affected the results of our study. In conclusion, old rats showed greater new bone regeneration and healing capacity for round mandibular bone defects. This result was related to the fact that the bone defects in the 20 M rat group provided more favorable conditions for new bone regeneration. Full article
Show Figures

Figure 1

Figure 1
<p>Micro-computed tomography analysis. (<b>A</b>) Bone volume/total volume (BV/TV), (<b>B</b>) bone mineral density (BMD), (<b>C</b>) trabecular thickness (TbTh), (<b>D</b>) trabecular space (TbSp), and (<b>E</b>) total volume (TV) of 2 M, 10 M, and 20 M groups. There was a significant difference in the BV, BMD, and TV among the three groups (* <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.001).</p>
Full article ">Figure 2
<p>The sagittal images of the micro-computed tomography of the mandible bone defect of (<b>A</b>) 2 M, (<b>B</b>) 10 M, and (<b>C</b>) 20 M groups. The new bone regeneration was observed from the edge of the bone defect.</p>
Full article ">Figure 3
<p>Three-dimensional (3D) reconstruction image of micro-computed tomography (μ-CT) of the mandible bone of (<b>A</b>) 2 M, (<b>B</b>) 10 M, and (<b>C</b>) 20 M groups. The new bone regeneration was more prominent in the 20 M group.</p>
Full article ">Figure 4
<p>Serum levels of (<b>A</b>) ALP, (<b>B</b>) PINP, (<b>C</b>) CTXI, and (<b>D</b>) TRAP5b. PINP levels in the 2 M group were significantly higher than those in the 10 M and 20 M groups at T0 (<span class="html-italic">p</span> = 0.026 and 0.002, respectively) and the 20 M group at T2 (<span class="html-italic">p</span> = 0.006). PINP levels in the 10 M group were significantly higher than those in the 20 M group (<span class="html-italic">p</span> = 0.020) at T2. The serum TRAP5b levels in the 10 M group were significantly higher than those in the 2 M group at T0, T1, and T2 (<span class="html-italic">p</span> = 0.039, 0.016, and 0.024, respectively) (* <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 5
<p>Histological images (hematoxylin and eosin staining) of each group. (<b>A</b>) 2 M, (<b>B</b>) 10 M, and (<b>C</b>) 20 M groups. A part of the new bone was formed at the end edge of the bone defect in the 2 M group. A remarkable bone regeneration was formed and covered the bone defect in the 10 M group. The thick and mature bone regeneration was observed in the 20 M group (original magnification 4×, scale bar = 1 mm).</p>
Full article ">Figure 6
<p>Immunohistochemical staining of ALP (<b>A</b>–<b>C</b>) and TRAP (<b>D</b>–<b>F</b>) in each group. (<b>A</b>,<b>D</b>) 2 M, (<b>B</b>,<b>E</b>) 10 M, and (<b>C</b>,<b>F</b>) 20 M group. ALP expression was observed in the osteogenic cells in the new bone matrix. TRAP expression was not specific in all groups (magnification 100×, scale bar = 100 µm).</p>
Full article ">
19 pages, 1086 KiB  
Article
Sonographic Features of Rectus Femoris Muscle in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease and Their Correlation with Body Composition Parameters and Muscle Strength: Results of a Single-Center Cross-Sectional Study
by Anna F. Sheptulina, Adel A. Yafarova, Elvira M. Mamutova and Oxana M. Drapkina
Biomedicines 2024, 12(8), 1684; https://doi.org/10.3390/biomedicines12081684 - 28 Jul 2024
Viewed by 301
Abstract
This study aimed to describe sonographic features of rectus femoris muscle (RFM) in patients with metabolic dysfunction-associated fatty liver disease (MASLD) and their correlation with body composition parameters and muscle strength. A total of 67 patients with MASLD underwent dual-energy X-ray absorptiometry (DEXA), [...] Read more.
This study aimed to describe sonographic features of rectus femoris muscle (RFM) in patients with metabolic dysfunction-associated fatty liver disease (MASLD) and their correlation with body composition parameters and muscle strength. A total of 67 patients with MASLD underwent dual-energy X-ray absorptiometry (DEXA), bioimpedance analysis (BIA), muscle strength measurement (grip strength [GS] and chair stand test [CST]), and ultrasound (US) investigation of the RFM in the dominant thigh using a 4 to 18 MHz linear probe. MASLD patients exhibited increased RFM echogenicity, possibly due to fatty infiltration. We confirmed that the greater the subcutaneous fat thickness, the smaller was the muscle mass (p < 0.001), and the lower was the muscle strength (p < 0.001 for GS and p = 0.002 for CST). On the contrary, the greater the anteroposterior diameter (APD) of RFM, the higher was the muscle mass (p < 0.001), and the greater was the muscle strength (p < 0.001 for GS and p = 0.007 for CST). In addition, APD of the RFM and stiffness of RFM exhibited direct correlation with bone mineral density values of the lumbar spine (p = 0.005 for both GS and CST). We concluded that US investigation of the RFM in the dominant thigh can be helpful in identifying MASLD patients at a high risk of musculoskeletal disorders given repeated point-of-care clinical evaluations. Full article
(This article belongs to the Special Issue Diagnosis, Pathogenesis and Treatment of Muscular Dystrophy)
Show Figures

Figure 1

Figure 1
<p>The distribution of patients with and without osteopenia by gender, age, skeletal muscle mass (SMM) and muscle strength. Patients with osteopenia did not differ significantly from patients without osteopenia in terms of their gender (<b>A</b>), age (<b>B</b>), SMM (<b>C</b>), and muscle strength (<b>D</b>,<b>E</b>). The line through the middle of each box represents the median. The length of the box, thus, represents the interquartile range. The error bars show the minimum and maximum values of each subscale. Outliers are depicted as circles and asterixis. All comparisons are performed using Mann–Whitney U test. BIA: bioelectrical impedance analysis; DEXA: dual-energy X-ray absorptiometry; NS: non-significant.</p>
Full article ">Figure 2
<p>US images of the rectus femoris muscle (RFM) in patients with MASLD. (<b>A</b>) US image of the RFM of a female MASLD patient aged 68 years (body mass index = 24.7 kg/m<sup>2</sup>). RFM echo intensity suggests Heckmatt grade II, which implies increased muscle gray-scale level with still distinct bone echo. (<b>B</b>) US image of the RFM in a female MASLD patient aged 53 years (body mass index = 33 kg/m<sup>2</sup>). RFM echo intensity corresponds to Heckmatt grades III–IV, which suggests a marked increase in muscle gray-scale level with decreased bone echo (III) or complete loss of bone echo (IV). Square: subcutaneous fat; asterisks: RFM; circle: vastus intermedius. The arrow indicates the bone echo in (<b>B</b>).</p>
Full article ">Figure 3
<p>Subcutaneous fat thickness, anteroposterior diameter (APD) of the RFM, and stiffness of the RFM in the dominant thigh in patients with and without osteopenia. The line through the middle of each box represents the median. The length of the box, thus, represents the interquartile range. The error bars show the minimum and maximum values of each subscale. Outliers are depicted as circles. All comparisons are carried out using Mann–Whitney U test.</p>
Full article ">
14 pages, 2619 KiB  
Article
Comparative Analysis of Morphometric, Densitometric, and Mechanical Properties of Skeletal Locomotor Elements in Three Duck Species (Anatidae: Anatinae)
by Cezary Osiak-Wicha, Ewa Tomaszewska, Siemowit Muszyński, Marian Flis, Michał Świetlicki and Marcin B. Arciszewski
Animals 2024, 14(15), 2191; https://doi.org/10.3390/ani14152191 - 27 Jul 2024
Viewed by 378
Abstract
Ducks (Anatinae) play a crucial role in wetland ecosystems, contributing to seed dispersal and nutrient cycling. This study investigates the skeletal adaptations of three duck species: the Mallard (Anas platyrhynchos), Tufted Duck (Aythya fuligula), and Green-Winged Teal [...] Read more.
Ducks (Anatinae) play a crucial role in wetland ecosystems, contributing to seed dispersal and nutrient cycling. This study investigates the skeletal adaptations of three duck species: the Mallard (Anas platyrhynchos), Tufted Duck (Aythya fuligula), and Green-Winged Teal (Anas crecca). The focus is on the tibiotarsus and humerus bones to understand how these adaptations support their different locomotion and habitat preferences. Bone samples n = 6 of deceased ducks (both male and female) from each species (for a total of 36 samples) were cleaned and measured for length, weight, and density. Dual-energy X-ray absorptiometry was used to determine bone mineral density (BMD) and bone mineral content (BMC), and mechanical properties like yield force and stiffness were tested using a 3-point bending test. The results show significant differences in body weight, bone weight, and bone length among the species, with Mallards being the largest and Teals the smallest. Male Teals displayed higher relative bone weight (RBW) in their tibia compared to male Mallards, and male Mallards had significantly lower RBW in the humerus compared to the other species. Female Teals had higher RBW than the other species. Teals also exhibited much lower BMD in the tibia, whereas female Mallards had lower BMD in the humerus. The Seedor index revealed that male Mallards had the highest values in the tibia, while female Teals had the lowest. Mechanical testing indicated that Teals had lower yield force and breaking force in the tibia, whereas Mallards showed the highest stiffness in both bones. Tufted Ducks had intermediate values, consistent with their diving behaviour. These findings suggest that the Mallard’s robust bones support its adaptability to various environments and diverse locomotion and foraging strategies. The Teal’s lighter and less dense bones facilitate rapid flight and agility in shallow wetlands. The Tufted Duck’s intermediate bone characteristics reflect its specialization in diving, requiring a balance of strength and flexibility. Understanding these skeletal differences may provide valuable insights into the evolutionary biology and biomechanics of these species, aiding in their conservation and enhancing our knowledge of their roles in wetland ecosystems. By exploring the functional morphology of these ducks, this study aims to shed light on the biomechanical mechanisms that underpin their locomotion and foraging behaviours. Full article
(This article belongs to the Section Animal Physiology)
Show Figures

Figure 1

Figure 1
<p>Comparative morphology of the long bones between the three duck species: (<b>A</b>) Mallard humerus, (<b>B</b>) Tufted Duck humerus, (<b>C</b>) Teal humerus, (<b>D</b>) Mallard tibia, (<b>E</b>) Tufted Duck tibia, (<b>F</b>) Teal tibia.</p>
Full article ">Figure 2
<p>Analysis of body dimensions between the Tufted Duck, Mallard and Teal duck species males and females: (<b>A</b>) body weight, (<b>B</b>) bone weight, (<b>C</b>) relative bone weight, (<b>D</b>) bone length, (<b>E</b>) sternal crest high to sternum length ratio. The letters indicate significant differences between species, with uppercase letters denoting distinctions among males and lowercase letters representing variations among females. Statistical significance was determined at <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 3
<p>Analysis of differences in tibia and humerus properties between the Tufted Duck, Mallard and Teal duck species males and females: (<b>A</b>) bone mineral density, (<b>B</b>) bone mineral content (<b>C</b>) Seedor index. The letters indicate significant differences between species, with uppercase letters denoting distinctions among males and lowercase letters representing variations among females. Hash (#) indicates significant differences between sexes within one species. Statistical significance was determined at <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 4
<p>Analysis of differences in tibia and humerus geometrical properties between the Tufted Duck, Mallard and Teal duck species males and females: (<b>A</b>) transversal outer diameter, (<b>B</b>) transversal inner diameter, (<b>C</b>) anteroposterior outer diameter, (<b>D</b>) anteroposterior inner diameter, (<b>E</b>) mid-diaphysis cross-sectional area, (<b>F</b>) mean relative wall thickness, (<b>G</b>) cortical index, (<b>H</b>) cross-sectional moment of inertia. The letters indicate significant differences between species, with uppercase letters denoting distinctions among males and lowercase letters representing variations among females. Hash (#) indicates significant differences between sexes within one species. Statistical significance was determined at <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 5
<p>Analysis of differences in tibia and humerus mechanical properties between the Tufted Duck, Mallard and Teal duck species males and females: (<b>A</b>) yield force, (<b>B</b>) elastic work, (<b>C</b>) stiffness, (<b>D</b>) breaking force, (<b>E</b>) breaking work. The letters indicate significant differences between species, with uppercase letters denoting distinctions among males and lowercase letters representing variations among females. Hash (#) indicates significant differences between sexes within one species. Statistical significance was determined at <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 6
<p>Analysis of differences in tibia and humerus bone material properties between the Tufted Duck, Mallard and Teal duck species males and females: (<b>A</b>) yield strain, (<b>B</b>) yield stress, (<b>C</b>) breaking strain, (<b>D</b>) breaking stress, (<b>E</b>) Young’s modulus. The letters indicate significant differences between species, with uppercase letters denoting distinctions among males and lowercase letters representing variations among females. Hash (#) indicates significant differences between sexes within one species. Statistical significance was determined at <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">
16 pages, 3226 KiB  
Article
The Role of Glucose, Insulin and Body Fat in Assessment of Bone Mineral Density and Trabecular Bone Score in Women with Functional Hypothalamic Amenorrhea
by Elżbieta Sowińska-Przepiera, Mariola Krzyścin, Igor Syrenicz, Adrianna Orlińska, Adrianna Ćwiertnia, Adam Przepiera, Karolina Jezierska, Aneta Cymbaluk-Płoska, Žana Bumbulienė and Anheli Syrenicz
J. Clin. Med. 2024, 13(15), 4388; https://doi.org/10.3390/jcm13154388 - 26 Jul 2024
Viewed by 475
Abstract
Background: For years, bone mineral density (BMD) has played a key role in assessing bone health, but the trabecular bone score (TBS) is emerging as an equivalent measure. However, BMD alone may not fully measure bone quality or predict osteoporosis risk. To evaluate [...] Read more.
Background: For years, bone mineral density (BMD) has played a key role in assessing bone health, but the trabecular bone score (TBS) is emerging as an equivalent measure. However, BMD alone may not fully measure bone quality or predict osteoporosis risk. To evaluate the usefulness of TBS and BMD in estimating the risk of bone fracture in young women with FHA, this study examined the association between metabolic parameters and bone quality, which was measured using TBS and BMD. Methods: We analyzed the association of metabolic factors with tests assessing bone quality—TBS and BMD. Patients were checked for BMI, measured body fat, and determined serum glucose levels and insulin levels in a 75g glucose load test. Spearman correlation analysis was used. Results: Significant positive correlations were found between BMD and age (p < 0.001) and body fat (p < 0.001), as well as between TBS values and BMI (p < 0.001) and TBS and percent body fat (p < 0.001). Of the variables analyzed in the multivariate analysis, the only independent predictor of higher bone mineral density in the lumbar spine was found to be higher values of the trabecular bone index in the same segment (p < 0.001). Conclusions: The use of TBS provides a simple tool for estimating the risk of bone damage. Ultimately, early screening, diagnosis and treatment of patients with FHA may help prevent osteoporosis and fragility fractures in the long term. Full article
Show Figures

Figure 1

Figure 1
<p>Distribution of Bone Mineral Density (BMD L1—L4, g/cm<sup>2</sup>) in the Lumbar Spine Among Study Participants.</p>
Full article ">Figure 2
<p>Trabecular Bone Score (TBS L1—L4) Values in the Lumbar Spine Among Study Participants.</p>
Full article ">Figure 3
<p>Relationship between lumbar spine trabecular bone score values and bone mineral density in the same segment BMD L1—L4, g/cm<sup>2</sup> [<span class="html-italic">p</span> &lt; 0.001; R = 0.33].</p>
Full article ">Figure 4
<p>Relationship between lumbar spine bone mineral density (BMD L1—L4, g/cm<sup>2</sup>) and age of study participants [0.026; R = 0.153].</p>
Full article ">Figure 5
<p>Relationship between lumbar spine bone mineral density (BMD L1–L4, g/cm<sup>2</sup>) and body mass index of study participants [<span class="html-italic">p</span> &lt; 0.001; R = 0.39].</p>
Full article ">Figure 6
<p>Relationship between lumbar spine bone mineral density (BMD L1—L4, g/cm<sup>2</sup>) and percent body fat of study participants [<span class="html-italic">p</span> &lt; 0.000; R = 0.284].</p>
Full article ">Figure 7
<p>Relationship between lumbar spine bone mineral density (BMD L1—L4, g/cm<sup>2</sup>) and fasting insulin levels in female participants [<span class="html-italic">p</span> &lt; 0.016; R = 0.17].</p>
Full article ">Figure 8
<p>Relationship between values of the trabecular bone score and body mass index values in female study participants [<span class="html-italic">p</span> &lt; 0.001; R = 0.28].</p>
Full article ">Figure 9
<p>Relationship between the values of the trabecular bone score and percent body fat in female participants [<span class="html-italic">p</span> &lt; 0.012; R = 0.18].</p>
Full article ">
10 pages, 527 KiB  
Article
Osteoarthritic Bony Alterations of Temporomandibular Joint and Relation to Low Bone Mineral Density in Postmenopausal Edentulous Females
by Laura Krumpane, Evija Nikitina, Laura Neimane, Andris Abeltins, Una Soboleva and Anda Slaidina
Dent. J. 2024, 12(8), 238; https://doi.org/10.3390/dj12080238 - 26 Jul 2024
Viewed by 320
Abstract
This study aimed to evaluate the relationship between osteoarthritic bony alterations in the temporomandibular joint (TMJ) and general bone mineral density (BMD) in postmenopausal edentulous females. Cone beam computed tomography (CBCT) scans for both TMJs were acquired for 80 clinically asymptomatic patients (mean [...] Read more.
This study aimed to evaluate the relationship between osteoarthritic bony alterations in the temporomandibular joint (TMJ) and general bone mineral density (BMD) in postmenopausal edentulous females. Cone beam computed tomography (CBCT) scans for both TMJs were acquired for 80 clinically asymptomatic patients (mean age 72 ± 8.8 y). Both lumbar spine and femoral neck measurements of BMD were performed using dual-energy X-ray absorptiometry (DXA). The most frequently observed bony alterations were flattening of the articular surface (47.5%), sclerosis (41.5%), subcortical cysts (10%), and erosions (5%). Osteophytes were not observed. No statistical differences were observed between those who had or did not have radiological signs of bony alterations according to age or DXA scores. The prevalence of radiological findings of degenerative TMJ bony alterations in clinically asymptomatic postmenopausal females did not confirm a connection with a generally low BMD. Full article
Show Figures

Figure 1

Figure 1
<p>Violin plots for T-scores (DXA) of spine, hips and worst for healthy individuals and individuals with radiological signs of osteoarthritis. DXA—dual-energy X-ray absorptiometry.</p>
Full article ">
11 pages, 914 KiB  
Article
Development of a Multidisciplinary Care Pathway for Fracture Prevention in Men with Prostate Cancer at Initiation of Androgen Deprivation Therapy
by Marsha M. van Oostwaard, Joop P. van den Bergh, Agnes J. van de Wouw, Marc de Jong, Maryska L. Janssen-Heijnen and Caroline E. Wyers
Cancers 2024, 16(15), 2665; https://doi.org/10.3390/cancers16152665 - 26 Jul 2024
Viewed by 363
Abstract
Fracture risk is increased in men with prostate cancer (PCa) receiving Androgen Deprivation Therapy (ADT). However, routine assessment of fracture risk is often not systematically applied. We aimed to establish a comprehensive care pathway for fracture prevention in men with PCa starting ADT. [...] Read more.
Fracture risk is increased in men with prostate cancer (PCa) receiving Androgen Deprivation Therapy (ADT). However, routine assessment of fracture risk is often not systematically applied. We aimed to establish a comprehensive care pathway for fracture prevention in men with PCa starting ADT. Therefore, a multidisciplinary working group designed and implemented a care pathway using the ‘Knowledge to Action’ framework, based on current Dutch guidelines for PCa, osteoporosis and fracture prevention, and an extensive literature review of other guidelines. The pathway was developed according to a five-step clinical approach including case finding, fracture risk assessment based on risk factors, bone mineral density test, vertebral fracture assessment, differential diagnosis, treatment, and annual follow-up. Our fracture prevention care pathway for patients with PCa at the time of ADT initiation was designed to promote a patient-centered, multidisciplinary approach to facilitate the implementation of early fracture prevention measures. Full article
(This article belongs to the Special Issue Contemporary Diagnosis and Management of Prostate Cancer)
Show Figures

Figure 1

Figure 1
<p>Summary of the care pathway for fracture prevention in men with prostate cancer starting or receiving treatment with androgen deprivation therapy. BMD: bone mineral density; DXA: Dual energy X-ray Absorptiometry; SECOB: secondary osteoporosis and other metabolic bone diseases; AOM: Anti-osteoporosis medication. * Crohn’s disease and ulcerative colitis, chronic malnutrition, malabsorption, celiac disease, rheumatoid arthritis, spondylarthritis (ankylosing spondylitis), SLE, sarcoidosis, anorexia nervosa, hypopituitarism, COPD, organ transplant, diabetes mellitus with insulin treatment, untreated hyperthyroidism or chronically over-substituted hypothyroidism.</p>
Full article ">Figure 2
<p>Treatment algorithm of the care pathway for fracture prevention in prostate cancer. PCa = prostate cancer; ADT = androgen deprivation therapy; SECOB: secondary osteoporosis and other metabolic bone diseases; AOM: anti-osteoporosis medication; DXA: dual energy X-ray absorptiometry; VFA = vertebral fracture assessment; BMD: bone mineral density; T = T-score; VF = vertebral fracture; Ca = calcium; D = vitamin D; IV = intravenously; SC = subcutaneously.</p>
Full article ">
15 pages, 1873 KiB  
Review
Bone Tissue Changes in Individuals Living with HIV/AIDS: The Importance of a Hierarchical Approach in Investigating Bone Fragility
by Jelena Jadzic, Gordana Dragovic, Relja Lukic, Bozana Obradovic and Marija Djuric
J. Pers. Med. 2024, 14(8), 791; https://doi.org/10.3390/jpm14080791 - 26 Jul 2024
Viewed by 523
Abstract
Skeletal alterations and their complications can significantly impact the quality of life and overall prognosis of patients living with HIV (PLWHIV). Considering skeletal alterations are often asymptomatic and unapparent during routine clinical evaluation, these conditions are frequently overlooked in the clinical management of [...] Read more.
Skeletal alterations and their complications can significantly impact the quality of life and overall prognosis of patients living with HIV (PLWHIV). Considering skeletal alterations are often asymptomatic and unapparent during routine clinical evaluation, these conditions are frequently overlooked in the clinical management of PLWHIV. However, since the use of combined antiretroviral therapy (cART) has increased life expectancy in PLWHIV effectively, osteopenia, osteoporosis, and bone fragility are now considered to have a major health impact, with a substantial increase in healthcare costs. This narrative literature review aimed to provide a comprehensive overview of the contemporary literature related to bone changes in PLWHIV, focusing on the importance of taking a multi-scale approach in the assessment of bone hierarchical organization. Even though a low bone mineral density is frequently reported in PLWHIV, numerous ambiguities still remain to be solved. Recent data suggest that assessment of other bone properties (on various levels of the bone structure) could contribute to our understanding of bone fragility determinants in these individuals. Special attention is needed for women living with HIV/AIDS since a postmenopausal status was described as an important factor that contributes to skeletal alterations in this population. Further research on complex etiopathogenetic mechanisms underlying bone alterations in PLWHIV may lead to the development of new therapeutic approaches specifically designed to reduce the health burden associated with skeletal disorders in this population. A major challenge in the clinical management of PLWHIV lies in the adverse skeletal effects of some frequently prescribed cART regimens (e.g., regimens containing tenofovir disoproxil fumarate), which may require a switch to other pharmacological approaches for maintained HIV infection (e.g., regimens containing tenofovir alafenamide). Taken together, the findings are indicative that the HIV/AIDS status should be taken into consideration when designing new guidelines and strategies for individualized prevention, diagnosis, and treatment of increased bone fragility. Full article
(This article belongs to the Section Methodology, Drug and Device Discovery)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Bone strength determinants in PLWHIV: the importance of the multi-scale approach in the assessment of bone hierarchical organization. Since low-intensity force (a fall from standing height) is not sufficient to fracture a healthy bone, this is indicative that the main cause of increased bone fragility originates from the structural bone features. It is important to note that the contemporary literature contains limited data about submicro- and nano-scale bone properties in PLWHIV, warranting further research.</p>
Full article ">Figure 2
<p>Schematic representation of molecular mechanisms contributing to bone alterations in patients living with HIV/AIDS. The figure contains multiple factors leading to bone changes in PLWHIV, with an emphasis on the factors that cause reduced bone formation and factors that stimulate bone resorption (the activating effect is marked with a green sign, while the deactivating effect is marked with a red sign; upward arrow symbol indicate higher concentrations, while downward arrow symbol indicate lower concentration of the molecule). Abbreviations: PTH—parathyroid hormone; IL—interleukin; TNF-α—tumor necrosis factor-α; ALP—alkaline phosphatase; OC—osteocalcin; OPG—osteoprotegerin; Vpr—viral protein R; M-CSF—macrophage colony-stimulating factor; Tat—trans-activator of transcription; RANK—receptor activator for nuclear factor-kappa B; RANKL—receptor activator for nuclear factor kappa B ligand; BMP-2—bone morphogenic factor-2.</p>
Full article ">
Back to TopTop